Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361

Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775

Detection of large-scale variation in the human genome

Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892

The Polycomb group protein EZH2 directly controls DNA methylation

Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204

Mutation in TET2 in Myeloid Cancers

Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Morin, R. D., Johnson, N. A., Severson, T., Mungall, A. J. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,719

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596

Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex

Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A. K., Wild, B., Miller, E., O’Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,553

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,536

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,064

EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency

Shen, X., Liu, Y., Hsu, Y.-J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G.-C., & Orkin, S. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.016 · Cited by 1,021

Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms

Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C. L. F., Dynlacht, B. D., & Reinberg, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.11.004 · Cited by 930

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

Beillard, E. J., Pallisgaard, N., van der Velden, V. H. J., Bi, W., Dee, R., van der Schoot, C. E., Delabesse, É., Macintyre, E. A., Gottardi, E. M., Saglio, G. N., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403136 · Cited by 887

Roles of the EZH2 histone methyltransferase in cancer epigenetics

Simon, J. A., & Lange, C. A. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 880

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784

Acquired mutations in TET2 are common in myelodysplastic syndromes

Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 755

Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation

Cui, K., Zang, C., Roh, T., Schones, D. E., Childs, R. W., Peng, W., & Zhao, K. (2009) · Cell stem cell · doi:10.1016/j.stem.2008.11.011 · Cited by 646

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

Kondo, Y., Shen, L., Cheng, A. S. L., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi‐Addo, B., et al. (2008) · Nature Genetics · doi:10.1038/ng.159 · Cited by 632

Polycomb group proteins: navigators of lineage pathways led astray in cancer

Bracken, A. P., & Helin, K. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2736 · Cited by 523

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Jones, A. V., Chase, A., Silver, R. T., Oscier, D. G., Zoi, K., Wang, Y. L., Cario, H., Pahl, H. L., Collins, A. R., Reiter, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.334 · Cited by 407

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Grand, F., Hidalgo-Curtis, C., Ernst, T., Zoi, K., Zoi, C., McGuire, C., Kreil, S., Jones, A. V., Score, J., Metzgeroth, G., et al. (2009) · Blood · doi:10.1182/blood-2008-12-194548 · Cited by 379

The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion

Kamminga, L. M., Bystrykh, L. V., de Boer, A., Houwer, S., Douma, J., Weersing, E., Dontje, B., & de Haan, G. (2006) · Blood · doi:10.1182/blood-2005-09-3585 · Cited by 376

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Fiskus, W. C., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Üstün, C., Rao, R., Fernandez, P., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213496 · Cited by 372

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

Gondek, L. P., Tiu, R. V., O’Keefe, C. L., Sekeres, M. A., Theil, K. S., & Maciejewski, J. P. (2007) · Blood · doi:10.1182/blood-2007-05-092304 · Cited by 318

An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders.

Cross, N. C. P., Melo, J. V., Feng, L., & Goldman, J. M. (1994) · PubMed · Cited by 257

Highly Sensitive Method for Genomewide Detection of Allelic Composition in Nonpaired, Primary Tumor Specimens by Use of Affymetrix Single-Nucleotide–Polymorphism Genotyping Microarrays

Yamamoto, G., Nannya, Y., Kato, M., Sanada, M., Levine, R. L., Kawamata, N., Hangaishi, A., Kurokawa, M., Chiba, S., Gilliland, D. G., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518809 · Cited by 242

PcG Proteins, DNA Methylation, and Gene Repression by Chromatin Looping

Tiwari, V. K., McGarvey, K. M., Licchesi, J. D. F., Ohm, J. E., Herman, J. G., Schübeler, D., & Baylin, S. B. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060306 · Cited by 214

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha.

Jones, A., Silver, R., Waghorn, K., Curtis, C., Kreil, S., Zoi, K., Hochhaus, A., Oscier, D., Metzgeroth, G., Lengfelder, E., et al. (2005) · Blood · doi:10.1182/blood-2005-09-3917 · Cited by 132

Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein

Holland, D., Hoppe‐Seyler, K., Schuller, B., Lohrey, C., Maroldt, J., Dürst, M., & Hoppe‐Seyler, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1134 · Cited by 110

Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders

Döhner, K., Hehmann, U., Brown, J. M., Hetzel, C., Stewart, J., Lowther, G. W., Scholl, C., Fröhling, S., Cuneo, A., Tsui, L. ‐., et al. (2001) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-18156-6_3 · Cited by 94

Methylation-Sensitive High-Resolution Melting-Curve Analysis of the SNRPN Gene as a Diagnostic Screen for Prader-Willi and Angelman Syndromes

White, H., Hall, V. J., & Cross, N. C. P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.093351 · Cited by 93

Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics

Heinrichs, S., Kulkarni, R. V., Bueso‐Ramos, C. E., Levine, R. L., Loh, M. L., Li, C., Neuberg, D. S., Kornblau, S. M., Issa, J. J., Gilliland, D. G., et al. (2009) · Leukemia · doi:10.1038/leu.2009.82 · Cited by 90

Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia

Gupta, M., Raghavan, M., Gale, R. E., Chelala, C., Allen, C. G., Molloy, G. Y., Chaplin, T., Linch, D. C., Cazier, J., & Young, B. D. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20573 · Cited by 90

Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders

Döhner, K., Brown, J. M., Hehmann, U., Hetzel, C., Stewart, J., Lowther, G. W., Scholl, C., Fröhling, S., Cuneo, A., Tsui, L., et al. (1998) · Blood · doi:10.1182/blood.v92.11.4031 · Cited by 87

Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line

Karanikolas, B. D. W., Figueiredo, M. L., & Wu, L. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0121 · Cited by 68

The SKM-1 Leukemic Cell Line Established from a Patient with Progression to Myelomonocytic Leukemia in Myelodysplastic Syndrome (MDS)-Contribution to Better Understanding of MDS

Nakagawa, T., & Matozaki, S. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509056841 · Cited by 41

Growth and differentiation of the human megakaryoblastic cell line (ELF- 153): a model for early stages of megakaryocytopoiesis

Mouthon, M., Freund, M., Titeux, M., Katz, A., Guichard, J., Breton-Gorius, J., & Vainchenker, W. (1994) · Blood · doi:10.1182/blood.v84.4.1085.1085 · Cited by 34

Cancer Cytogenetics

(2010) · Wiley eBooks · doi:10.1002/9781118010136 · Cited by 22

Mitotic recombination in haematological malignancy

Raghavan, M., Gupta, M., Molloy, G. Y., Chaplin, T., & Young, B. D. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.030 · Cited by 5

Regulation of chromatin by histone modifications

Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012

The Polycomb complex PRC2 and its mark in life

Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347

Cancer epigenetics: from mechanism to therapy

Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203

A decade of exploring the cancer epigenome—biological and translational implications

Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871

Histone methylation: a dynamic mark in health, disease and inheritance

Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241

EZH2 Mutations: Mutating the Epigenetic Machinery in Myeloid Malignancies

Abdel-Wahab, O. I., & Levine, R. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.006 · Cited by 10

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

Nikoloski, G., Langemeijer, S. M. C., Kuiper, R. P., Knops, R., Massop, M., Tönnissen, E., van der Heijden, A., Scheele, T. N., Vandenberghe, P., de Witte, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.620 · Cited by 777

Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders

Ernst, T., Chase, A., Score, J., Hidalgo-Curtis, C., Bryant, C., Jones, A. E., Waghorn, K., Zoi, K., Ross, F., Reiter, A., et al. (2010)

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Score, J., Hidalgo-Curtis, C., Jones, A. V., Winkelmann, N., Skinner, A., Ward, D., Zoi, K., Ernst, T., Stegelmann, F., Döhner, K., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367243 · Cited by 177

Mitotic recombination in haematological malignancy

Raghavan, M., Gupta, M., Molloy, G. Y., Chaplin, T., & Young, B. D. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.030 · Cited by 5